Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2017

Open Access 01-11-2017 | Introduction

WHO guidelines on testing for hepatitis B and C – meeting targets for testing

Authors: Margaret E. Hellard, Roger Chou, Philippa Easterbrook

Published in: BMC Infectious Diseases | Special Issue 1/2017

Login to get access

Excerpt

An estimated 71 million people worldwide are chronically infected with hepatitis C [1] and 257 million with hepatitis B [1‐4]. Combined, hepatitis C and hepatitis B are estimated to cause 1.34 million deaths annually, and viral hepatitis is now the 7th leading cause of death globally, ahead of HIV and malaria [2, 3]. The burden of hepatitis B and C disease in 2013 was estimated at 38.7 million disability-adjusted life years (DALYs), an increase of at least 25% since 1990 [3, 4]. …
Literature
1.
2.
Lozano R, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed
3.
Stanaway JD, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388(10049):1081–8.CrossRefPubMedPubMedCentral
4.
5.
6.
Wei L, Lok AS. Impact of new hepatitis C treatments in different regions of the world. Gastroenterology. 2014;146(5):1145–50. e1-4CrossRefPubMed
7.
McMahon BJ, et al. Internist diagnosis and Management of Chronic Hepatitis B Virus Infection. Am J Med. 2012;125(11):1063–7.CrossRefPubMed
8.
9.
10.
11.
Chou R, Easterbrook P, Hellard M. Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infection. BMC Infect Dis. 2017;17(Suppl 1). doi:10.​1186/​s12879-017-2766-1.
Metadata
Title
WHO guidelines on testing for hepatitis B and C – meeting targets for testing
Authors
Margaret E. Hellard
Roger Chou
Philippa Easterbrook
Publication date
01-11-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue Special Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2765-2

Other articles of this Special Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue

Review

Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa

Research

Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples – a systematic review and meta-analysis

Research

Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature

Review

The future of viral hepatitis testing: innovations in testing technologies and approaches

Research

Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses

Research

Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits